Ultragenyx Pharmaceutical (RARE) 10-K2018 FY Annual report

Filed: 20 Feb 19, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: advice, ANVISA, appealed, appetite, Article, assumption, Bedrosian, Brazil, Brexit, Camille, Canadian, chelation, childhood, Chile, clarity, Codification, Columbia, concurrence, conditionally, construct, conventional, copper, corn, Crysvita, customer, demographic, district, divergent, DMC, earliest, electorate, expedient, familiar, FDII, genotype, GILTI, hepatic, highest, Huang, hub, hyperammonemia, immigration, infancy, inherited, jaundice, John, Karah, Kassberg, lactic, liberalization, Liechtenstein, lifelong, Lisbon, LS, LUNA, Montreal, native, navigating, notably, null, Parschauer, Pinion, psychiatric, PTE, rarest, rebound, reclassification, referendum, regime, retail, science, Shehnaaz, shut, shutdown, slightly, SPC, starch, steroid, Suliman, Synlogic, TFP, tie, Treaty, Trifunctional, unconstitutional, untreated, UPENN, VIII, weaned

Removed: abnormal, absence, absolute, aceneuramic, acknowledged, addressed, adulthood, airway, allergy, anticipation, antiepileptic, apnea, arthralgia, attempting, bind, blinded, Braun, bringing, calcium, calling, cartilage, cathepsin, cellular, chalky, close, commercialized, complication, confirmatory, CRO, crossed, decade, developmental, diagnose, diary, dihydroxy, dosed, eIND, emerging, extremity, facial, feedback, fever, GAG, GUS, half, headache, hormone, hospital, hypercalciuria, hyperparathyroidism, inclusion, indirect, insufficiency, intact, intraday, investor, Jude, ketogenic, ketone, leverage, licensee, lt, LUNAR, lung, missing, monogenetic, mutation, nanoparticle, nutraceutical, nutritional, obstruction, Oligomer, organ, outsourcing, owner, parathyroid, phenotype, PPCA, pre, precedent, prefer, protective, Question, reabsorption, reach, refractory, registration, released, renegotiate, repatriation, rhPPCA, RSS, scoring, screened, seizure, sleep, St, step, stool, strongly, supplying, tolerability, tolerate, tracheostomy, translational, UNA, upper, urinary, velocity, walking, warrant, Washington, withdrew, worst

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated RARE transcripts

RARE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 21.1

Significant Subsidiaries of Ultragenyx Pharmaceutical Inc.


Name of Subsidiary		Jurisdiction of Incorporation
Dimension Therapeutics, Inc.		Delaware
Ultragenyx Holdco LLC		Delaware
Ultragenyx Argentina SRL		Argentina
Ultragenyx Brasil Farmacêutica Ltda.		Brazil
Ultragenyx Canada Inc.		Canada
Ultragenyx International Ltd.		Cayman Islands
Ultragenyx International UX001 Ltd.		Cayman Islands
Ultragenyx International UX003 Ltd.		Cayman Islands
Ultragenyx International UX007 Ltd.		Cayman Islands
Ultragenyx International UX0023 Ltd.		Cayman Islands
Ultragenyx Colombia SAS		Colombia
Ultragenyx France SAS		France
Ultragenyx Germany GmbH		Germany
Ultragenyx Mexico, S. de R.L. de C.V.		Mexico
Ultragenyx Netherlands B.V.		Netherlands
Ultragenyx Europe GmbH		Switzerland
Ultragenyx UK Ltd		United Kingdom

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.